Nwam LLC cut its position in shares of Clorox Company (The) (NYSE:CLX) by 10.0% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,659 shares of the company’s stock after selling 406 shares during the period. Nwam LLC’s holdings in Clorox Company (The) were worth $488,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Korea Investment CORP boosted its position in Clorox Company (The) by 938.9% in the first quarter. Korea Investment CORP now owns 178,197 shares of the company’s stock worth $24,026,000 after buying an additional 161,044 shares during the period. Crossvault Capital Management LLC boosted its position in Clorox Company (The) by 3.8% in the first quarter. Crossvault Capital Management LLC now owns 34,684 shares of the company’s stock worth $4,676,000 after buying an additional 1,285 shares during the period. Ameriprise Financial Inc. boosted its position in Clorox Company (The) by 2.4% in the first quarter. Ameriprise Financial Inc. now owns 1,076,072 shares of the company’s stock worth $146,932,000 after buying an additional 25,110 shares during the period. Destination Wealth Management boosted its position in Clorox Company (The) by 14.0% in the first quarter. Destination Wealth Management now owns 30,225 shares of the company’s stock worth $4,075,000 after buying an additional 3,716 shares during the period. Finally, Janney Capital Management LLC purchased a new position in Clorox Company (The) during the first quarter worth about $216,000. Institutional investors own 70.29% of the company’s stock.

Clorox Company (CLX) opened at 133.94 on Friday. Clorox Company has a one year low of $111.24 and a one year high of $141.76. The firm has a market cap of $17.29 billion, a price-to-earnings ratio of 25.11 and a beta of 0.40. The stock has a 50 day moving average of $133.72 and a 200 day moving average of $133.47.

Clorox Company (The) (NYSE:CLX) last announced its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, topping analysts’ consensus estimates of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.65 billion. During the same quarter last year, the firm earned $1.30 earnings per share. Clorox Company (The)’s quarterly revenue was up 2.9% on a year-over-year basis. Equities research analysts predict that Clorox Company will post $5.68 EPS for the current fiscal year.

WARNING: “Clorox Company (The) (NYSE:CLX) Shares Sold by Nwam LLC” was first posted by Daily Political and is owned by of Daily Political. If you are reading this piece on another publication, it was copied illegally and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece can be viewed at https://www.dailypolitical.com/2017/08/11/clorox-company-the-nyseclx-shares-sold-by-nwam-llc.html.

A number of research analysts have recently issued reports on CLX shares. Deutsche Bank AG reiterated a “hold” rating and issued a $137.00 target price (up previously from $126.00) on shares of Clorox Company (The) in a research note on Saturday, July 22nd. Vetr upgraded shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $139.67 target price for the company in a research note on Monday, April 24th. Jefferies Group LLC assumed coverage on shares of Clorox Company (The) in a research note on Tuesday, April 18th. They issued a “hold” rating and a $138.00 target price for the company. BMO Capital Markets restated a “buy” rating and issued a $136.00 price objective on shares of Clorox Company (The) in a research report on Thursday, May 4th. Finally, Zacks Investment Research cut shares of Clorox Company (The) from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the company’s stock. Clorox Company (The) has an average rating of “Hold” and a consensus price target of $129.05.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.